Thus, the characterization of CD8+ T cells either isolated from the tumor site or chronically stimulated in vitro convincingly shows that expression of CD38 on Tex cells is primarily associated with the terminally differentiated subset that fails to respond to anti-PD1 therapy. The gene discussed is CD38; the disease is neoplasm.